• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Dental Pain - Pipeline Review, H1 2013 - Product Image

Dental Pain - Pipeline Review, H1 2013

  • Published: May 2013
  • 42 pages
  • Global Markets Direct

Dental Pain – Pipeline Review, H1 2013

Summary

Global Markets Direct’s, 'Dental Pain - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Dental Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Pain. Dental Pain - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Dental Pain.
- A review of the Dental Pain products under development by companies and universities/research institutes based on information derived from READ MORE >

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Dental Pain Overview
Therapeutics Development
An Overview of Pipeline Products for Dental Pain
Dental Pain Therapeutics under Development by Companies
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Dental Pain Therapeutics – Products under Development by Companies
Companies Involved in Dental Pain Therapeutics Development
Novartis AG
Pfizer Inc.
IBSA Institut Biochimique SA
NeuroDiscovery Ltd
Array BioPharma Inc.
Dental Pain – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
ARRY-797 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NSL-101 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
diclofenac sodium - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SAF-312-A - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PF-05089771 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
29B-S - Drug Profile
Product Description
Mechanism of Action
R&D Progress
18c-S - Drug Profile
Product Description
Mechanism of Action
R&D Progress
34B-S - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Dental Pain Therapeutics – Drug Profile Updates
Dental Pain Therapeutics – Discontinued Products
Dental Pain Therapeutics - Dormant Products
Dental Pain – Product Development Milestones
Featured News & Press Releases
Jun 21, 2012: Iroko Pharma Announces Phase III Study Results Of Diclofenac
Nov 04, 2011: Phase II Results For Nano-formulated NSAIDs Under Development At Iroko Pharmaceuticals To Be Reported At ACR Meeting
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Dental Pain, H1 2013
Products under Development for Dental Pain – Comparative Analysis, H1 2013
Number of Products under Development by Companies, H1 2013
Comparative Analysis by Late Stage Development, H1 2013
Comparative Analysis by Mid Clinical Stage Development, H1 2013
Comparative Analysis by Early Clinical Stage Development, H1 2013
Products under Development by Companies, H1 2013
Novartis AG, H1 2013
Pfizer Inc., H1 2013
IBSA Institut Biochimique SA, H1 2013
NeuroDiscovery Ltd, H1 2013
Array BioPharma Inc., H1 2013
Assessment by Monotherapy Products, H1 2013
Assessment by Combination Products, H1 2013
Assessment by Stage and Route of Administration, H1 2013
Assessment by Stage and Molecule Type, H1 2013
Dental Pain Therapeutics – Drug Profile Updates
Dental Pain Therapeutics – Discontinued Products
Dental Pain Therapeutics – Dormant Products
Dental Pain Therapeutics – Dormant Products (Contd..1)

List of Figures
Number of Products under Development for Dental Pain, H1 2013
Products under Development for Dental Pain – Comparative Analysis, H1 2013
Products under Development by Companies, H1 2013
Late Stage Products, H1 2013
Mid Clinical Stage Products, H1 2013
Early Clinical Stage Products, H1 2013
Assessment by Monotherapy Products, H1 2013
Assessment by Combination Products, H1 2013
Assessment by Route of Administration, H1 2013
Assessment by Stage and Route of Administration, H1 2013
Assessment by Molecule Type, H1 2013
Assessment by Stage and Molecule Type, H1 2013 24

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos